Literature DB >> 12812308

Hypophysopexy technique for radiosurgical treatment of cavernous sinus pituitary adenoma.

William T Couldwell1, Joshua M Rosenow, Richard L Rovit, Deborah L Benzil.   

Abstract

Stereotactic radiosurgery is being used with increased frequency in the treatment of residual or recurrent pituitary adenomas. The major risk associated with radiosurgical treatment of residual or recurrent pituitary tumor adjacent to normal functional pituitary gland is radiation of the pituitary, which frequently leads to the development of hypopituitarism. The authors describe a technique of pituitary transposition to reduce the radiation dose to the normal pituitary gland in cases of planned radiosurgical treatment of residual pituitary adenoma within the cavernous sinus. A sellar exploration for tumor resection is performed, the pituitary gland is transposed from the region of the cavernous sinus, and a fat and fascia graft is interposed between the normal pituitary gland and the residual tumor in the cavernous sinus. The residual tumor may then be treated with stereotactic radiosurgery. The increased distance between the normal pituitary gland and the residual tumor facilitates treatment of the tumor with radiosurgery and reduces the radiation to the normal pituitary gland. An illustrative case of a young female with recurrent acromegaly and a pituitary adenoma invading the cavernous sinus is described.

Entities:  

Mesh:

Year:  2002        PMID: 12812308     DOI: 10.1023/a:1023313232296

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  17 in total

1.  Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.

Authors:  A L Barkan; I Halasz; K J Dornfeld; C A Jaffe; R D Friberg; W F Chandler; H M Sandler
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

2.  Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.

Authors:  A Abosch; J B Tyrrell; K R Lamborn; L T Hannegan; C B Applebury; C B Wilson
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

3.  Tight control of growth hormone: an attainable outcome for acromegaly treatment.

Authors:  S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

4.  Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.

Authors:  A M Landolt; D Haller; N Lomax; S Scheib; O Schubiger; J Siegfried; G Wellis
Journal:  J Neurosurg       Date:  1998-06       Impact factor: 5.115

5.  Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients.

Authors:  D A Ross; C B Wilson
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

Review 6.  Radiosurgery for pituitary tumors and craniopharyngiomas.

Authors:  E R Laws; M L Vance
Journal:  Neurosurg Clin N Am       Date:  1999-04       Impact factor: 2.509

7.  Gamma knife radiosurgery as a primary treatment for prolactinomas.

Authors:  L Pan; N Zhang; E M Wang; B J Wang; J Z Dai; P W Cai
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

8.  Gamma knife radiosurgery for prolactinomas.

Authors:  A M Landolt; N Lomax
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

9.  Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck.

Authors:  N A Samaan; R Vieto; P N Schultz; M Maor; R T Meoz; V A Sampiere; A Cangir; H L Ried; R H Jesse
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

10.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

View more
  5 in total

Review 1.  Transsphenoidal and transcranial surgery for pituitary adenomas.

Authors:  William T Couldwell
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

2.  Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases.

Authors:  Motohiro Hayashi; Mikhail Chernov; Noriko Tamura; Mariko Nagai; Shoji Yomo; Taku Ochiai; Kosaku Amano; Masahiro Izawa; Tomokatsu Hori; Yoshihiro Muragaki; Hiroshi Iseki; Yoshikazu Okada; Kintomo Takakura
Journal:  J Neurooncol       Date:  2010-04-22       Impact factor: 4.130

3.  Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus.

Authors:  Graeme F Woodworth; Kunal S Patel; Benjamin Shin; Jan-Karl Burkhardt; Apostolos John Tsiouris; Edward D McCoul; Vijay K Anand; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2014-02-14       Impact factor: 5.115

Review 4.  The implications of microsurgical anatomy for surgical approaches to the sellar region.

Authors:  Gustavo Rassier Isolan; Paulo Henrique Pires de Aguiar; Edward R Laws; Atahualpa Cauê Paim Strapasson; Otávio Piltcher
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 5.  Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques.

Authors:  Giuseppe Minniti; Marie-Lise Jaffrain-Rea; Mattia Osti; Giampaolo Cantore; Riccardo Maurizi Enrici
Journal:  Neurosurg Rev       Date:  2007-05-05       Impact factor: 2.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.